- Home
- KNF vs PTGX Comparison
KNF vs PTGX Comparison
Compare KNF & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNF | PTGX |
|---|---|---|
| Founded | 1917 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | KNF | PTGX |
|---|---|---|
| Price | $87.56 | $104.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $97.25 | ★ $108.23 |
| AVG Volume (30 Days) | 483.7K | ★ 669.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.76 | N/A |
| Revenue | ★ $3,146,012,000.00 | N/A |
| Revenue This Year | $9.38 | $873.97 |
| Revenue Next Year | $5.49 | N/A |
| P/E Ratio | $32.19 | ★ N/A |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $58.72 | $41.29 |
| 52 Week High | $101.02 | $107.84 |
Technical Indicators
Market Signals| Indicator | KNF | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 57.18 |
| Support Level | $75.76 | $77.82 |
| Resistance Level | $92.91 | $107.84 |
| Average True Range (ATR) | 3.65 | 3.73 |
| MACD | 0.69 | -0.16 |
| Stochastic Oscillator | 82.40 | 81.68 |
Price Performance
Historical ComparisonAbout KNF Knife Riv Holding Co.
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. The segments of the company include West, Mountain, Central, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.